$MREO 4 SEC Filings

Filed On	Filing
27 Feb 2026	Form 4: Jacquet Pierre, Director Granted 66,000 Share Options (Right to buy) · Granted 106,848 Deferred Restricted Stock Units
27 Feb 2026	Form 4: Yoskowitz Marc J, Director Granted 66,000 Share Options (Right to buy) · Granted 96,163 Deferred Restricted Stock Units
27 Feb 2026	Form 4: Shames Daniel, Director Granted 66,000 Share Options (Right to buy) · Granted 96,163 Deferred Restricted Stock Units
27 Feb 2026	Form 4: Bender Jeremy, Director Granted 66,000 Share Options (Right to buy) · Granted 117,533 Deferred Restricted Stock Units
27 Feb 2026	Form 4: Pakianathan Deepika, Director Granted 66,000 Share Options (Right to buy)
27 Feb 2026	Form 4: Jenkins Annalisa, Director Granted 66,000 Share Options (Right to buy) · Granted 106,848 Deferred Restricted Stock Units
27 Feb 2026	Form 4: Ekblom Anders, Director Granted 66,000 Share Options (Right to buy) · Granted 133,560 Deferred Restricted Stock Units
27 Feb 2026	Form 4: Wyzga Michael S, Director Granted 66,000 Share Options (Right to buy)
02 Feb 2026	Form 4: Lewicki John A., Chief Scientific Officer Granted 331,550 Share Options (Right to buy)
02 Feb 2026	Form 4: Hughes-Wilson Alexandra, See Remarks Granted 440,000 Share Options (Right to buy)
02 Feb 2026	Form 4: Sermon Charles, General Counsel Granted 716,000 Share Options (Right to buy)
02 Feb 2026	Form 4: Scots-Knight Denise, Director Granted 1,860,000 Share Options (Right to buy)
02 Feb 2026	Form 4: Fox Christine Ann, Chief Financial Officer Granted 701,000 Share Options (Right to buy)
06 Feb 2025	Form 4: Yoskowitz Marc J, Director Granted 55,000 Share Options (Right to buy) · Granted 13,719 Deferred Restricted Stock Units
06 Feb 2025	Form 4: Pakianathan Deepika, Director Granted 55,000 Share Options (Right to buy)
06 Feb 2025	Form 4: Bender Jeremy, Director Granted 55,000 Share Options (Right to buy) · Granted 16,768 Deferred Restricted Stock Units
06 Feb 2025	Form 4: Ekblom Anders, Director Granted 55,000 Share Options (Right to buy) · Granted 19,054 Deferred Restricted Stock Units
06 Feb 2025	Form 4: Shames Daniel, Director Granted 55,000 Share Options (Right to buy) · Granted 13,719 Deferred Restricted Stock Units
06 Feb 2025	Form 4: Wyzga Michael S, Director Granted 55,000 Share Options (Right to buy) · Granted 30,487 Deferred Restricted Stock Units
06 Feb 2025	Form 4: Jenkins Annalisa, Director Granted 55,000 Share Options (Right to buy) · Granted 15,243 Deferred Restricted Stock Units

Comments